£0.00
0
0
Subtotal: £0.00

No products in the basket.

Epilepsy facts and figures

This page shows useful information from key references. You can find epilepsy research priorities identified through consensus work and guidance development here.

If you have any suggestions for additions or changes, please contact [email protected].

About epilepsy

  1. Epilepsy is one of the most common serious neurological conditions.1
  2. In the UK, around one in 100 people live with epilepsy [UK point prevalence 9.37 per 1000 population]; epilepsy affects 630,000 people.2
  3. Around 30% of people live with uncontrolled seizures.3
  4. There are three epilepsy-related deaths every day.4
  5. About 100,000 people present to hospitals each year in England with an epileptic seizure.5
  6. There are approximately 40,000 epilepsy-related admissions to English hospitals per annum (1.4% of all emergency medical admissions).5
  7. There are an estimated 60,000 attendances at emergency departments in England for epilepsy.5
  8. Research in a large region of England found suspected seizures represented 0.71% of Emergency Department attendances:6
    • 89.8% of people arrived by emergency ambulance
    • 45.4% of people were admitted
    • 44.5% of the admissions lasted under 48 hours.
  9. In 2018–19, there were 45,924 finished admission episodes with primary diagnosis of epilepsy in England.7
  10. Rare and complex epilepsies affect nearly 5 people in 10,000 of the general population (European data).8

Cost

  1. Using 2019 data:9
    • the average annual cost per person with epilepsy ranged from $204 in low-income countries to $11,432 in high-income countries [based on “a highly skewed database”].
    • applying per person costs to the estimated 52.51 million people in the world with epilepsy and adjusting for the treatment gap, the total global cost of epilepsy was $119.27 billion.
  2. Health economic data are lacking. “The original NICE guideline on epilepsy (2004) stated that the annual estimated cost of established epilepsy was £2 billion (direct and indirect costs). However, newer and more expensive antiseizure medications are now being prescribed. With an increase in treatment costs likely in coming years, it is essential to ensure that antiseizure medications with proven clinical and cost effectiveness are identified.”9a

Investment in epilepsy research

  1. UK Analysis of national data shows ~£18 million was spent on epilepsy research during 2022.10 In contrast, £107.9 million was invested in dementia research by the UK government in 2019/20:11, 12
    • NIHR funded £29 million
    • MRC funded £44 million
    • BBSRC funded £29 million
    • ESRC funded £5.9 million
    • Based on an estimate of 885,000 people aged 65 and older living with dementia in 2019,13 this equates to £121.92 per person with dementia (65+ years).
    • Based on an estimate of 630,000 people with epilepsy (see above), the research spend was £28.57 per person with epilepsy.
  2. USA The picture is similar – compare the scales for the y-axes.


Figure 1:
US research funding for epilepsy.14

Figure 2: US research funding for Alzheimer’s disease including related dementias.14

Risk factors

  1. People living in high and medium deprivation have an increased risk of incident epilepsy of around 34% and 23%, respectively, compared with those living in low deprivation.15

Historical perspective16

  1. The discovery of epilepsy can be dated back to around 2000 BCE in Mesopotamia, where one of the first written descriptions of epilepsy was recorded.
  2. In ancient Greece, where epilepsy was considered a divine punishment by the gods; in Sparta, all babies with epilepsy were left to die on Taygetus mountain.
  3. The word ‘epilepsy’ is originally derived from the ancient Greek word epilamanein, which means ‘to be possessed’ or ‘to be seized’.
  4. In 1875 Hughlings Jackson, the father of epilepsy, recognised that seizures were linked to abnormal electrical discharges occurring in the brain.

Epilepsy-associated deaths

  1. The most common causes of death directly linked to epilepsy are sudden unexpected death in epilepsy (SUDEP), status epilepticus, unintentional injuries, and suicide.17

References

  1. Thijs RD, Surges R, O’Brien TJ, Sander JW. Epilepsy in adults. Lancet 2019;393:689–701.https://doi.org/10.1016/S0140-6736(18)32596-0Back to top
  2. Wigglesworth S, Neligan A, Dickson JM et al. The incidence and prevalence of epilepsy in the United Kingdom 2013–2018: A retrospective cohort study of UK primary care data. Seizure 2023;105:37–42.https://doi.org/10.1016/j.seizure.2023.01.003Back to top
  3. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314–19.https://doi.org/10.1056/NEJM200002033420503Back to top
  4. In 2020 in England, Wales and Scotland, 916 people died with epilepsy recorded as the underlying cause (2.5 deaths/day). More recent data are available for Scotland but not England and Wales. Data for Northern Ireland do not appear to be available. Back to top
  5. Dixon PA, Kirkham JJ, Marson AG, et al. National Audit of Seizure management in Hospitals (NASH): results of the national audit of adult epilepsy in the UK. BMJ Open 2015;5:e007325.https://doi.org/10.1136/bmjopen-2014-007325Back to top
  6. Hughes-Gooding T, Dickson JM, O’Keeffe C, Mason SM. A data linkage study of suspected seizures in the urgent and emergency care system in the UK. Emerg Med J 2020;37(10):605–610.https://doi.org/10.1136/emermed-2019-208820Back to top
  7. Hospital admissions for epilepsy – NHS England Digital response to media query.No resource URL available.Back to top
  8. EpiCARE. About Epilepsies. Accessed July 2025.https://epi-care.eu/about-epilepsiesBack to top
  9. Begley C, Wagner RG, Abraham A, et al. The global cost of epilepsy: A systematic review and extrapolation. Epilepsia 2022;63:892–903.https://doi.org/10.1111/epi.17165Back to top
9a. National Institute for Health and Care Excellence (NICE). Epilepsies in children, young people and adults. NG217; last updated 30 January 2025.
https://www.nice.org.uk/guidance/ng217 Back to top
  1. Epilepsy Research Institute. Identification and analysis of epilepsy research grants from HRCS 2022 report. Data on file.No resource URL available.Back to top
  2. Written question from Chi Onwurah (BEIS), December 2021.No resource URL available.Back to top
  3. Written question from Chi Onwurah (DHSC), June 2023.No resource URL available.Back to top
  4. Wittenberg R, Hu B, Barraza-Araiza L et al. Projections of older people living with dementia and costs of dementia care in the United Kingdom, 2019–2040. London School of Economics, 2019.No resource URL available.Back to top
  5. NIH RePORT: Research Portfolio Online Reporting Tools. Categorical spending dashboard.https://report.nih.gov/funding/categorical-spending#/Back to top
  6. Bush KJ, Cullen E, Mills S et al. Assessing the extent and determinants of socioeconomic inequalities in epilepsy in the UK: a systematic review and meta-analysis. Lancet Public Health 2024;9:e614–28.https://doi.org/10.1016/S2468-2667(24)00132-4Back to top
  7. Ahmed A, Rahman AH, Williams S et al. Seizures and epilepsy: an overview for UK medical students. Cureus 2024;16:e70654.https://doi.org/10.7759/cureus.70654Back to top
  8. Thurman DJ, Logroscino G, Beghi E et al. The burden of premature mortality of epilepsy in high-income countries: A systematic review. Epilepsia 2017;58:17–26.https://doi.org/10.1111/epi.13604Back to top
×